NCT03417778View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

August 9, 2018

Study Completion Date

August 9, 2018

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Filgotinib

100 mg tablet administered orally

Trial Locations (4)

1010

Auckland Clinical Studies Ltd., Grafton

33014

Clinical Pharmacology of Miami, Miami

78215

American Research Corporation at the Texas Liver Institute, San Antonio

81241

APEX GmbH, Munich

Sponsors

Lead Sponsor

Gilead Sciences

Collaborators (1)

All Listed Sponsors

collaborator

Galapagos NV

INDUSTRY

lead

Gilead Sciences

INDUSTRY